REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction
Full name: Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Profile Updated: February 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Immunolab is a Polish company that develops and implements vaccines and immunological preparations for the prevention and treatment of various diseases in animals, particularly swine and broiler infections caused by pathogenic bacteria such as E coli and Campylobacter jejuni. The company also manufactures diagnostic products, including sera for serological diagnosis of Salmonella. Immunolab's main activities include the production and sale of biological products for health and veterinary services in Poland, as well as accepting individual orders from Scientific Institutes.

Headquarters
Ul. Kladki 24
Gdansk; Pomorskie; Postal Code: 80-822

Contact Details: Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.

Website: http://www.immunolab.com.pl

Basic Information
Total Employees:
Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.
Incorporation Date:
March 13, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Natvet Sp. z o.o.
46.25%
Company Performance
Financial values in the chart are available after Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
51.99%▲
Total operating revenue
14.4%▲
Operating profit (EBIT)
-84.51%▼
EBITDA
-75.4%▼
Net Profit (Loss) for the Period
-90.47%▼
Total assets
-13.91%▼
Total equity
10.39%▲
Operating Profit Margin (ROS)
-73.92%▼
Net Profit Margin
-66.67%▼
Return on Equity (ROE)
-62%▼
Debt to Equity Ratio
-4.27%▼
Quick Ratio
0.17%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo